Invivyd CFO sells 40.8K shares for tax withholding
Invivyd, Inc. (IVVD) reported that its Chief Financial Officer, William E. Duke, converted 102,000 restricted stock units into an equal number of common shares on August 15, 2026, as part of a scheduled vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Invivyd, Inc. (IVVD) reported that its Chief Financial Officer, William E. Duke, converted 102,000 restricted stock units into an equal number of common shares on August 15, 2026, as part of a scheduled vesting. The underlying RSU award vests in thirds every six months over an eighteen‑month period from February 15, 2025. To cover tax withholding from this vesting, he then sold a total of 40,780 shares of common stock in open-market, non‑discretionary sell‑to‑cover transactions pursuant to a pre‑arranged Rule 10b5‑1 plan adopted on February 20, 2025, at weighted average prices of $0.722 (range $0.682–$0.830) on August 17 and $0.8429 (range $0.760–$0.872) on August 18.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F2, F4 | 18,425 | $0.8429 | $16K |
| Sale | Common Stock F2, F3 | 22,355 | $0.722 | $16K |
| Exercise | Restricted Stock Units F1, F5 | 102,000 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 102,000 | -- | -- |
Footnotes (5)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Invivyd, Inc. (the "Company").
- F2. The sales reported on this Form 4 represent shares sold to satisfy the Reporting Person's tax withholding obligations upon vesting of an RSU award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on February 20, 2025.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.682 to $0.830, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.760 to $0.872, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- F5. This RSU award vests over an eighteen-month period, with one-third of the RSUs vesting every six months following the grant date of February 15, 2025, subject to the Reporting Person's continuous service as of each vesting date.
Key Figures
Key Terms
restricted stock unit financial
Rule 10b5-1 plan regulatory
sell-to-cover financial
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Invivyd (IVVD) report for CFO William E. Duke?
Were the recent Invivyd (IVVD) insider sales made under a Rule 10b5-1 plan?
What RSU vesting did Invivyd (IVVD) disclose for its CFO?
What type of securities were involved in the Invivyd (IVVD) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.